Introduction: The future of our healthcare services highly depends on the current generation of health science students since they are the ones who will work in the healthcare setting. Ensuring their mental well-being is an utmost priority so that they can offer top-tier quality care and services to people in need. This study aimed to explore the prevalence of mental well-being and mental help-seeking attitude among undergraduate sciences students and the impact of socioeconomic status toward both variables.
Materials And Methods: A cross-sectional study was conducted among students (N = 364) from six sciences schools at International Islamic University Malaysia via an online survey, which contained three main parts; socioeconomic status, mental well-being assessment using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), and assessment of mental help-seeking attitude using the General Mental Help-Seeking Attitude Scale (MHSAS). Data were analysed using SPSS, version 29.0.
Results: Only 7.1% of the students have positive mental well-being, while 44.8% scored positive mental help-seeking attitude. There were no significant differences ( > 0.05) in students' mental well-being and any of SES components. There was a significant association between students' year of study and mental help-seeking attitude ( = 0.029), in addition, WEMWBS and MHSAS scores showed a positive correlation ( < 0.01).
Conclusion: Future studies are essential to find out the contributing factors, prevention, and intervention that can be done to help the student in need.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11648585 | PMC |
http://dx.doi.org/10.4103/jpbs.jpbs_802_24 | DOI Listing |
Background: In Alzheimer's Disease trials, the Mini-Mental State Examination (MMSE) and Clinical Dementia Rating (CDR) are commonly utilized as inclusionary criteria at screening. These measures, however, do not always reaffirm inclusionary status at baseline. Score changes between screening and baseline visits may imply potential score inflation at screening leading to inappropriate participant enrollment.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China.
Background: The DL-3-n-butylphthalide (NBP), a multi-target neuroprotective drug, improving cognitive impairment in patient with vascular cognitive impairment has been confirmed. The efficacy of NBP in patients with cognitive impairment due to Alzheimer's disease (AD) remains unknown. This study aimed to evaluate the efficacy and safety of NBP in patients with mild cognitive impairment (MCI) due to AD though a clinical randomized controlled trail.
View Article and Find Full Text PDFBackground: Senile dementia (SD) is a deteriorative organic brain disorder and it comprises Alzheimer's disease (AD) as a major variant. SD is shown impairment of mental capacities whereas AD is degeneration of neurons. According to World Health Organization (WHO) report; more than 55 million peoples have dementia and it is raising 10 million new cases every year.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Centre for Addiction and Mental Health, Toronto, ON, Canada.
Background: Dysregulated GABA/somatostatin (SST) signaling has been implicated in psychiatric and neurodegenerative disorders. The inhibition of excitatory neurons by SST+ interneurons, particularly through α5-containing GABAA receptors (α5-GABAAR), plays a crucial role in mitigating cognitive functions. Previous research demonstrated that an α5-positive allosteric modulator (α5-PAM) mitigates working memory deficits and reverses neuronal atrophy in aged mice.
View Article and Find Full Text PDFBackground: Selecting the optimal dose for clinical development is especially problematic for drugs directed at CNS-specific targets. For drugs with a novel mechanism of action, these problems are often greater. We describe Xanamem's clinical pharmacology, including the approach to dose selection and proof-of-concept studies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!